Latest Australian Market News

Page 1 of 32
Sunrise Energy Metals has received unconditional FIRB approval for its proposed move to the United States, removing a key condition for the scheme. The company is targeting shareholder and Court approvals in January, with Nasdaq and ASX CDI trading expected to begin in February 2027.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Enero Group delivered stronger FY26 earnings and a $24.5 million net cash position, but its new financial year has opened with group EBITDA down 28% as Hotwire and BMF absorb restructuring and client losses. Orchard’s record quarter and rising AI revenue provide the counterweight, but execution remains the central test.
Victor Sage
Victor Sage
6 Nov 2026
Marimaca Copper ended September with US$126.6 million in cash and US$135.5 million in net working capital, giving the pre-revenue Chilean developer funding visibility for at least the next year. A potential US$17.3 million VAT recovery could add to that liquidity in the first half of 2027, but the Marimaca Project has not yet reached demonstrable technical feasibility or commercial viability.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Elixir Energy has told ASX that its $205 million strategic farm-out with Beach Energy was material price-sensitive information and became disclosable when documents were signed. The company says it released the deal before trading resumed and remained compliant with continuous disclosure rules.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Monash IVF Group’s underlying NPAT fell 41% to A$16.1 million in FY26, missing its recently reduced guidance as softer Australian IVF activity outweighed international growth. A second-half market-share recovery, lower planned capital spending and a new productivity program now carry the FY27 investment case.
Ada Torres
Ada Torres
23 Oct 2026
Transurban’s Group average daily traffic rose 3.1% year on year in the September quarter, with Melbourne, North America and Sydney leading the portfolio higher. The update also corrects recent North American traffic and pricing data, with no reported revenue impact.
Victor Sage
Victor Sage
21 Oct 2026
EBR Systems has submitted its WiSE wireless cardiac pacing system for Australian regulatory approval, opening a potential second commercial market after the United States. The application has entered a priority review pathway, but neither approval nor an assessment timetable is guaranteed.
Victor Sage
Victor Sage
20 Oct 2026
Stockland has maintained its FY27 earnings, distribution and settlement targets despite softer residential demand and longer customer decision times. Logistics and retail remain firm, while the group’s data centre pipeline now has approximately 450MW of power secured.
Eva Park
Eva Park
19 Oct 2026
ARB Corporation’s FY26 profit fell 5.2% as weaker Australian aftermarket and OEM sales outweighed modest export growth. The 4x4 accessories maker is relying on improved vehicle supply, US expansion and new product programs to rebuild momentum in FY27.
Victor Sage
Victor Sage
15 Oct 2026
Barramundi Limited (NZX:BRM) has reported the worst performance in its 20-year history, with a NZ$42.9 million net loss and a 17.0% fall in gross portfolio performance. The board is reviewing Fisher Funds’ management performance just weeks before its five-year agreement comes up for renewal.
Claire Turing
Claire Turing
28 Sept 2026
BCAL Diagnostics has begun introducing ClearNote Health’s Avantect Multi-Cancer blood test in Australia, starting with Sydney and Melbourne. The test reported 56.2% sensitivity and 98.4% specificity in a case-control validation study, but the company says a negative result does not rule out cancer.
Ada Torres
Ada Torres
23 Sept 2026
S&P Dow Jones Indices has announced its September 2026 quarterly rebalance for the S&P/ASX indices, with significant reshuffling across major benchmarks effective before market open on September 21.
Claire Turing
Claire Turing
4 Sept 2026

Browse the archive

Full archive